Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use

Ida M. Heerfordt, Espen Jimenez‐Solem, Magnus Middelboe, Rasmus Huan Olsen, Henrik Horwitz

Open source

DOI
10.1111/bcpt.70086
Published
2025-07-15
Container
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.70086,
  title = {Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use},
  author = {Ida M. Heerfordt and Espen Jimenez‐Solem and Magnus Middelboe and Rasmus Huan Olsen and Henrik Horwitz},
  year = {2025},
  journal = {Basic \& Clinical Pharmacology \& Toxicology},
  doi = {10.1111/bcpt.70086},
  url = {https://doi.org/10.1111/bcpt.70086}
}

RIS

TY  - JOUR
TI  - Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use
AU  - Ida M. Heerfordt
AU  - Espen Jimenez‐Solem
AU  - Magnus Middelboe
AU  - Rasmus Huan Olsen
AU  - Henrik Horwitz
PY  - 2025
JO  - Basic & Clinical Pharmacology & Toxicology
DO  - 10.1111/bcpt.70086
UR  - https://doi.org/10.1111/bcpt.70086
ER  - 

APA

Heerfordt, I. M., Jimenez‐Solem, E., Middelboe, M., Olsen, R. H., & Horwitz, H. (2025). Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70086

Source records